焦躁腿综合征的循环节模式:对治疗的含义 剂量学
Celia Garcia-Malo1, Irene Cano-Pumarega1,2,3, Andrea Castro-Villacañas-Farzamnia1
1Neurology Department, Centro Integral de Sueño y Neurociencias (CISNe), Madrid, Spain.
Sleep science (Sao Paulo, Brazil)
|December 19, 2024
概括
不安腿综合征 (RLS) 的症状遵循一个日常节奏,受神经递质变化的影响. 了解这些昼夜模式是改善RLS治疗和有效管理症状的关键.
科学领域:
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
- 时间生物学 时间生物学
背景情况:
- 不安腿综合征 (RLS) 症状表现出一个昼夜模式,影响每日症状严重程度.
- 在RLS病理生理学中,昼夜节律的潜在驱动因素尚未完全理解.
- 神经递质系统与RLS有关,有潜在的昼夜变化.
研究的目的:
- 审查有关RLS中涉及的神经递质的昼夜变化的现有证据.
- 提供RLS疗法和当前治疗建议的概述.
- 突出需要对RLS昼夜振荡和个性化治疗调整进行进一步研究.
主要方法:
- 关于RLS的昼夜变化研究的文献综述.
- 在RLS中分析神经递质系统 (铁,腺素,多巴胺,谷氨酸,阿片类药物).
- 审查当前的RLS症状治疗指南和药物剂量.
主要成果:
- 对于RLS至关重要的神经递质存在循环变异,包括系统和大脑铁,腺素,多巴胺,谷氨酸和阿片类药物.
- 目前的RLS疗法提供症状缓解,但考虑到昼夜因素的最佳剂量策略缺乏.
- 针对昼夜RLS模式的个性化管理策略可以提高治疗效益.
结论:
- 昼夜节律在RLS症状表现和神经递质波动中起着重要作用.
- 对RLS的昼夜方面进行进一步的研究对于开发更有效,个性化的治疗方法至关重要.
- 根据昼夜因素优化药物治疗时间可能会提高RLS患者的治疗疗效.
相关概念视频
Restless Leg Syndrome and Night Terrors
149
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
149
Management of Insomnia
230
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
230
REM Sleep Behavior Disorder
143
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
143
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
41
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
41
Sedatives and Hypnotics Drugs: Miscellaneous Agents
145
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
145
Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K


